Updated follow-up data and biomarker analysis of pre-operative ipilimumab and nivolumab in locoregional advanced urothelial cancer (NABUCCO)
ESMO 2022
Contact Us To Get Started!
Work with us – your premier oncology partner – to optimize cancer care for patients